Visual Performance of Clareon® Vivity® and PureSee® Intraocular Lenses in Patients Undergoing Cataract Surgery
Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
This is study to determine the visual performance of patients with age-related cataracts implanted in both eyes with either of two extended depth of focus intraocular lenses, the Clareon Vivity (Alcon Healthcare) or the PureSee (Johnson \& Johnson)
Eligibility
Participation Requirements
Sex: All
Minimum Age: 50
Healthy Volunteers: f
View:
• Patients of any sex and race aged 50 years or older
• Patients undergoing bilateral age-related cataract surgery with a lens opacity grade 3 or higher in the LOCS III grading scale
• Willing to receive implantation of an EDOF IOL
• Willing to sign the informed consent and attend the study visits
Locations
Other Locations
Spain
OMIQ Research
RECRUITING
Sant Cugat Del Vallès
Time Frame
Start Date: 2025-06-27
Estimated Completion Date: 2026-03
Participants
Target number of participants: 80
Treatments
Experimental: Extended depth of focus intraocular lens Clareon Vivity
Active_comparator: Extended depth of focus intraocular lens PureSee
Related Therapeutic Areas
Sponsors
Leads: OMIQ Research